For the past several years, we have seen an increasing number of reports on the clinical application of proteomics research for risk assessment, diagnosis, prognosis, and management of cancer. These reports have generated a high level of excitement. At the same time, they have attracted critical
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: